Cover Image

Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy

Wen-Yu Zhai,1,2,&ast; Fang-Fang Duan,3,&ast; Yao-Bin Lin,1,2,&ast; Yong-Bin Lin,1,2 Ze-Rui Zhao,1,2 Jun-Ye Wang,1,2 Bing-Yu Rao,1,2 Lie Zheng,4 Hao Long1,2 1Department of Thoracic Surgery, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhai WY (Author), Duan FF (Author), Lin YB (Author), Zhao ZR (Author), Wang JY (Author), Rao BY (Author), Zheng L (Author), Long H (Author)
Format:	Book
Published:	Dove Medical Press, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
by: Yang Y, et al.
Published: (2023)

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
by: Ivy Riano, et al.
Published: (2023)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
by: Yan Hu, et al.
Published: (2022)

Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
by: Thomas Hansen, et al.
Published: (2024)

Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
by: Chao Zheng, et al.
Published: (2022)

Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection
by: Yurie Kogue, et al.
Published: (2023)

The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiotherapy
by: Zhang H, et al.
Published: (2024)

Clinical Value of Systemic Immune Inflammation and Pan-Immune Inflammation in Adenoid Hypertrophy
by: Tuğba Yemiş, et al.
Published: (2024)

Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
by: Luis A. Godoy, et al.
Published: (2023)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
by: Wenliang Liu, et al.
Published: (2022)

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery
by: Hyein Jeon, et al.
Published: (2024)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus'ko, et al.
Published: (2017)

Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML)
by: Maurizio Cianfriglia
Published: (2013)

Pharmacodynamics of Rivaroxaban and Dabigatran in Adults with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
by: Teerachat Punnachet, et al.
Published: (2024)

Prediction of immunochemotherapy response for diffuse large B‐cell lymphoma using artificial intelligence digital pathology
by: Jeong Hoon Lee, et al.
Published: (2024)

The Pan-Immune Inflammation Value at Admission Predicts Postoperative in-hospital Mortality in Patients with Acute Type A Aortic Dissection
by: Yu X, et al.
Published: (2024)

Pan-Cancer Screening and Validation of CALU’s Role in EMT Regulation and Tumor Microenvironment in Triple-Negative Breast Cancer
by: Chen SL, et al.
Published: (2024)

Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non‐small cell lung cancer
by: Wei Guo, et al.
Published: (2023)

The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma
by: Duan L, et al.
Published: (2024)

Obesity paradox in patients with non‐small cell lung cancer undergoing immune checkpoint inhibitor therapy
by: Ji Hyun Lee, et al.
Published: (2023)

Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer
by: Yan Hu, et al.
Published: (2022)

Recent Research Advances in Small-Molecule Pan-PIM Inhibitors
by: Lei Xu, et al.
Published: (2022)

The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
by: Yaling Wang, et al.
Published: (2020)

Family social support and the self-esteem of breast cancer patients undergoing neoadjuvant chemotherapy
by: Erik Aprilianto, et al.
Published: (2021)

Prognostic role of lymph node regression in patients with esophageal cancer undergoing neoadjuvant therapy
by: Pingrun Chen, et al.
Published: (2024)

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration
by: Junhan Wu, et al.
Published: (2024)

Naples Prognostic Score as an Independent Predictor of Survival Outcomes for Resected Locally Advanced Non-Small Cell Lung Cancer Patients After Neoadjuvant Treatment
by: Zou Z, et al.
Published: (2023)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018)

Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
by: Yi Wang, et al.
Published: (2024)

Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy
by: Yizel Becerril-Alarcón, et al.
Published: (2019)

INTEGRATION OF ECONOMIC AND COMPUTER SKILLS AT IMPLEMENTATION OF STUDENTS PROJECT «BUSINESS PLAN PRODUCING IN MICROSOFT WORD»
by: Y.B. Samchinska
Published: (2012)

Muramyl peptides in the complex treatment of cervical intraepithelial neoplasia associated with human papillomavirus
by: Y.B. Yakymchuk
Published: (2021)

Preoperative Anxiolytic and Sedative Effects of Intranasal Remimazolam and Dexmedetomidine: A Randomized Controlled Clinical Study in Children Undergoing General Surgeries
by: Cai YH, et al.
Published: (2024)

Clinical value of the detection of EGFR gene mutations in pleural effusion cell blocks among patients with non-small-cell lung cancer
by: Yijun Zhu, et al.
Published: (2021)

Prognostic implication and immunological value of contactin 1 expression in pan‐cancer
by: Lingyun Zhang, et al.
Published: (2022)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
by: Kangwei He, et al.
Published: (2022)

New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies
by: Chen D, et al.
Published: (2018)

Comprehensive analysis of prognostic value and immune infiltration of kindlin family members in non-small cell lung cancer
by: Xiaoshan Su, et al.
Published: (2021)

Pan-immune-inflammation value and body mass index to predict survival in diffuse large B-cell lymphoma
by: Mohamed Ahmed Abdel Hafez, et al.
Published: (2024)

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
by: Melissa Sarver, et al.
Published: (2022)